Abstract
Integrated positron emission tomography/computed tomography (PET/CT) has many advantages over solitary PET and CT, which has led it to become an increasingly established imaging technique in the management of many cancers. This article will review the evidence for the role of F-18-fluorodeoxyglucose PET/CT in non-small. cell lung cancer staging, examining its strengths, weaknesses and cost-effectiveness. (C) 2006 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 97-108 |
Number of pages | 12 |
Journal | Clinical Radiology |
Volume | 62 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2007 |